Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-015-2428-6
Published Online: 2015-06-20
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lucijanic, Marko
Lasan-Trcic, Ruzica
Kusec, Rajko
Pejsa, Vlatko
Stoos-Veic, Tajana
Jaksic, Ozren
Text and Data Mining valid from 2015-06-20